Brandinium

Trademark search for:

IMMUNARRAY

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2012-07-02 — Application filed
  • 2012-07-05 — Application filed
  • 2012-07-11 — Application filed
  • 2012-07-12 — Notice of pseudo mark mailed
  • 2012-10-23 — Assigned to examiner
  • 2012-10-29 — Final disposition recorded
  • 2012-10-31 — Final disposition recorded
  • 2012-12-05 — Teas/email correspondence entered
  • 2012-12-05 — Office action issued
  • 2012-12-05 — Correspondence received in law office
  • 2012-12-17 — Office action issued
  • 2012-12-18 — Office action issued
  • 2013-04-10 — Attorney/dom.rep.revoked and/or appointed
  • 2013-04-10 — Teas revoke/app/change addr of atty/dom rep received
  • 2013-04-15 — Examiners amendment -written
  • 2013-04-15 — Approved for pub - principal register
  • 2013-04-15 — Examiners amendment e-mailed
  • 2013-04-15 — Notification of examiners amendment e-mailed
  • 2013-04-15 — Examiner's amendment entered
  • 2013-04-26 — Assigned to lie
  • 2013-04-26 — Law office publication review completed
  • 2013-05-15 — Notification of notice of publication e-mailed
  • 2013-06-04 — Published for opposition
  • 2013-06-04 — Official gazette publication confirmation e-mailed
  • 2013-07-30 — Noa e-mailed - sou required from applicant
  • 2013-10-08 — Teas statement of use received
  • 2013-10-09 — Use amendment filed
  • 2013-11-12 — Case assigned to intent to use paralegal
  • 2013-11-14 — Statement of use processing complete
  • 2013-12-05 — Final disposition recorded
  • 2013-12-05 — Final disposition recorded
  • 2013-12-05 — Final disposition recorded
  • 2014-02-19 — Teas withdrawal of attorney received
  • 2014-02-19 — Withdrawal of attorney granted
  • 2014-06-12 — Office action issued
  • 2014-06-12 — Teas petition to revive received
  • 2014-06-17 — Assigned to petition staff
  • 2014-06-18 — Office action issued
  • 2014-06-18 — Notice of revival - mailed
  • 2014-07-09 — Office action issued
  • 2014-07-09 — Office action issued
  • 2014-07-11 — Undeliverable mail - no action taken
  • 2014-07-11 — Undeliverable mail - no action taken
  • 2015-01-08 — Teas request for reconsideration received
  • 2015-01-15 — Teas/email correspondence entered
  • 2015-01-15 — Correspondence received in law office
  • 2015-01-22 — Allowed principal register - sou accepted
  • 2015-01-23 — Notice of acceptance of statement of use mailed
  • 2015-02-24 — Registered-principal register
  • 2015-07-24 — Teas change of correspondence received
  • 2018-06-11 — Attorney/dom.rep.revoked and/or appointed
  • 2018-06-11 — Teas revoke/app/change addr of atty/dom rep received
  • 2018-06-12 — Teas change of owner address received
  • 2018-06-12 — Applicant/correspondence changes (non-responsive) entered
  • 2018-06-14 — Teas section 7 request received
  • 2018-06-29 — Case assigned to post registration paralegal
  • 2018-06-29 — Correction under section 7 - processed
  • 2018-08-28 — Case assigned to post registration paralegal
  • 2018-08-30 — Correction under section 7 - processed
  • 2020-02-24 — Courtesy reminder - sec. 8 (6-yr) e-mailed
  • 2021-10-01 — Cancelled sec. 8 (6-yr)
  • 2021-10-01 — Final status recorded

Owner Information

ImmunArray LTD
Rehovot IL
ImmunArray LTD
Rehovot IL
ImmunArray LTD
Rehovot IL

Correspondent

Barbara A. Friedman Edell Shapiro & Finnan LLC
9801 Washingtonian Boulevard, Suite 750
Gaithersburg, MD 20878
UNITED STATES

Filing Details

Filing Date:
2012-07-02
Status Date:
2021-10-01
Category:
Chemicals
Filing Year:
2012

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.